1. 120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q). Issue 1 (April 2015) Authors: Schuler, E.; Schemenau, J.; Giagounidis, A.; Haase, D.; Büsche, G.; Platzbecker, U.; Nolte, F.; Götze, K.; Schlenk, R.F.; Ganser, A.; Letsch, A.; Lübbert, M.; Schafhausen, P.; Bug, G.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗